[Diffuse interstitial pneumopathy after the treatment with gold salts of a patient with rheumatoid polyarthritis].
We present the case of a male patient with sero-negative rheumatoid arthritis, treated with gold salts, admitted for clinical symptoms and chest X-ray alterations suggesting an interstitial lung disease. This was confirmed by complex lung function tests and fiber bronchoscopy with broncho-alveolar lavage. Considerations are made about the etiology of interstitial lung disease (pulmonary determination of the rheumatoid arthritis or secondary to the gold salts therapy), about the treatment and long-term prognosis, and about the good clinical, functional and radiological evolution under treatment.
Strâmbu
I
I
UMF Carol Davila, Bucureşti.
Stoicescu
I P
IP
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D001999:Bronchoscopy; D005336:Fiber Optic Technology; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D050607:Organogold Compounds; D011859:Radiography; D012129:Respiratory Function Tests
D000305:Adrenal Cortex Hormones; D018501:Antirheumatic Agents; D050607:Organogold Compounds